Zlatko Janeba

2.0k total citations
127 papers, 1.7k citations indexed

About

Zlatko Janeba is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Zlatko Janeba has authored 127 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 55 papers in Infectious Diseases and 51 papers in Epidemiology. Recurrent topics in Zlatko Janeba's work include HIV/AIDS drug development and treatment (51 papers), Biochemical and Molecular Research (49 papers) and Pneumocystis jirovecii pneumonia detection and treatment (29 papers). Zlatko Janeba is often cited by papers focused on HIV/AIDS drug development and treatment (51 papers), Biochemical and Molecular Research (49 papers) and Pneumocystis jirovecii pneumonia detection and treatment (29 papers). Zlatko Janeba collaborates with scholars based in Czechia, United States and Belgium. Zlatko Janeba's co-authors include Martin Dračínský, Ondřej Baszczyňski, Antonı́n Holý, Petr Jansa, Dana Hocková, Morris J. Robins, Dianne T. Keough, Luke W. Guddat, Eliška Procházková and Lieve Naesens and has published in prestigious journals such as Nucleic Acids Research, Angewandte Chemie International Edition and Chemical Communications.

In The Last Decade

Zlatko Janeba

124 papers receiving 1.6k citations

Peers

Zlatko Janeba

EPIDE

Noriaki Minakawa Japan

Sonsoles Velázquez Spain

Ana San‐Félix Spain

Suzanne Peyrottes France

Chris Meier Germany

Krzysztof W. Pankiewicz United States

Vipender Singh United States

Ramachandra S. Hosmane United States

Hemalatha Balaram India

Milena Masojı́dková Czechia

Noriaki Minakawa Japan

Zlatko Janeba

1.7k ×2.0

662 ×1.0

418 ×0.7

299 ×0.6

EPIDE

80 ×0.7

Citations per year, relative to Zlatko Janeba Zlatko Janeba (= 1×) peers Noriaki Minakawa

Countries citing papers authored by Zlatko Janeba

Since Specialization

Citations

This map shows the geographic impact of Zlatko Janeba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zlatko Janeba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zlatko Janeba more than expected).

Fields of papers citing papers by Zlatko Janeba

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zlatko Janeba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zlatko Janeba. The network helps show where Zlatko Janeba may publish in the future.

Co-authorship network of co-authors of Zlatko Janeba

This figure shows the co-authorship network connecting the top 25 collaborators of Zlatko Janeba. A scholar is included among the top collaborators of Zlatko Janeba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zlatko Janeba. Zlatko Janeba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Keough, Dianne T., Lenka Poštová Slavětínská, Martin Dračínský, et al.. (2025). C1′‐Branched Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium Falciparum 6‐Oxopurine Phosphoribosyltransferase. ChemMedChem. 20(19). e202500575–e202500575.

Spiwok, Vojtěch, et al.. (2024). Developing Allosteric Inhibitors of SARS‐CoV‐2 RNA‐Dependent RNA Polymerase. ChemMedChem. 19(23). e202400367–e202400367. 1 indexed citations

Česnek, Michal, Jaroslav Kozák, Eva Tloušťová, et al.. (2024). Structure-Based Drug Design of ADRA2A Antagonists Derived from Yohimbine. Journal of Medicinal Chemistry. 67(12). 10135–10151. 3 indexed citations

Česnek, Michal, et al.. (2023). Discovery of a potent and selective human AC2 inhibitor based on 7-deazapurine analogues of adefovir. Bioorganic & Medicinal Chemistry. 95. 117508–117508. 2 indexed citations

Keough, Dianne T., Gordon J. King, Eva Doleželová, et al.. (2022). Stereo-Defined Acyclic Nucleoside Phosphonates are Selective and Potent Inhibitors of Parasite 6-Oxopurine Phosphoribosyltransferases. Journal of Medicinal Chemistry. 65(5). 4030–4057. 7 indexed citations

Procházková, Eliška, Juraj Filo, Martin Dračínský, et al.. (2022). Photoswitching of 5-phenylazopyrimidines in crystalline powders and thin films. Dyes and Pigments. 199. 110066–110066. 4 indexed citations

Doleželová, Eva, et al.. (2022). Synthesis and anti-trypanosomal evaluation of novel N-branched acyclic nucleoside phosphonates bearing 7-aryl-7-deazapurine nucleobase. European Journal of Medicinal Chemistry. 239. 114559–114559. 2 indexed citations

Doleželová, Eva, Petr Pachl, Lenka Poštová Slavětínská, et al.. (2021). C1′-Branched acyclic nucleoside phosphonates mimicking adenosine monophosphate: Potent inhibitors of Trypanosoma brucei adenine phosphoribosyltransferase. European Journal of Medicinal Chemistry. 225. 113798–113798. 4 indexed citations

Zı́dek, Zdeňek, et al.. (2021). Polysubstituted Pyrimidines as Potent Inhibitors of Prostaglandin E₂ Production: Increasing Aqueous Solubility. ChemMedChem. 16(18). 2802–2806. 4 indexed citations

10.

Slavětínská, Lenka Poštová, et al.. (2020). Efficient Synthesis of α-Branched Purine-Based Acyclic Nucleosides: Scopes and Limitations of the Method. Molecules. 25(18). 4307–4307. 7 indexed citations

11.

Ajani, Haresh, et al.. (2020). Polysubstituted Pyrimidines as mPGES‐1 Inhibitors: Discovery of Potent Inhibitors of PGE₂ Production with Strong Anti‐inflammatory Effects in Carrageenan‐Induced Rat Paw Edema. ChemMedChem. 15(15). 1398–1407. 12 indexed citations

12.

Filo, Juraj, Martin Dračínský, Chavdar Slavov, et al.. (2020). Polysubstituted 5‐Phenylazopyrimidines: Extremely Fast Non‐ionic Photochromic Oscillators. Angewandte Chemie. 132(36). 15720–15724. 3 indexed citations

13.

Baszczyňski, Ondřej, et al.. (2020). Development of Scalable Synthesis of 5-Butyl-4-(4-methoxyphenyl)-6-phenylpyrimidin-2-amine (WQE-134), a Dual Inhibitor of Nitric Oxide and Prostaglandin E₂ Production. Organic Process Research & Development. 24(9). 1718–1724. 5 indexed citations

14.

Dračínský, Martin, et al.. (2019). Synthesis of Tetrasubstituted Thiophenes via Direct Metalation. The Journal of Organic Chemistry. 85(2). 788–797. 3 indexed citations

15.

Bray, Mike, Graciela Andreï, Ester Ballana, et al.. (2018). Meeting report: 31st International Conference on Antiviral Research. Antiviral Research. 158. 88–102. 8 indexed citations

16.

Jansa, Petr, et al.. (2018). Influence of the C-5 substitution in polysubstituted pyrimidines on inhibition of prostaglandin E2 production. European Journal of Medicinal Chemistry. 156. 295–301. 10 indexed citations

17.

Kind, Jonas, Martin Dračínský, Juraj Filo, et al.. (2018). Photoswitching Behavior of 5-Phenylazopyrimidines: In Situ Irradiation NMR and Optical Spectroscopy Combined with Theoretical Methods. The Journal of Organic Chemistry. 83(11). 5986–5998. 22 indexed citations

18.

Andreï, Graciela, Kara Carter, Zlatko Janeba, et al.. (2017). Highlights of the 30th International Conference on Antiviral Research. Antiviral Research. 145. 184–196. 10 indexed citations

19.

Procházková, Eliška, et al.. (2017). Photoswitchable Intramolecular Hydrogen Bonds in 5‐Phenylazopyrimidines Revealed By In Situ Irradiation NMR Spectroscopy. Chemistry - A European Journal. 24(2). 492–498. 31 indexed citations

20.

Dračínský, Martin, et al.. (2016). Design and Synthesis of Fluorescent Acyclic Nucleoside Phosphonates as Potent Inhibitors of Bacterial Adenylate Cyclases. ChemMedChem. 11(22). 2534–2546. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact